Abstract
A novel experimental model was established in normal rats for studying the localisation and tissue distribution of a murine monoclonal antibody directed against kappa light chain B cell malignancies. The antibody, K-1-21 was raised against human kappa Bence Jones Proteins and reacts with a cell membrane antigen KMA which is restricted to some kappa myeloma and lymphoma cells. In the rat model, kappa or lambda Bence Jones protein-conjugated sepharose was implanted subcutaneously on either flank 24 h before the injection of 131I-labelled K-1-21 or its F(ab′)2 fragment. Gamma camera imaging and tissue distribution studies showed specific localisation of the K-1-21 antibody in the kappa sepharose. Injection of F(ab′)2 antibody fragments resulted in faster background clearance, earlier delineation of the specific image and significantly higher target to blood ratios than those obtained with the intact antibody. These results suggest that the model may provide an alternative system to tumour xenograft bearing nude mice for studying localisation of antibodies with therapeutic potential.
Similar content being viewed by others
References
Ballou B, Reiland J, Levine G, Knowles B, Hakala TR (1985) Tumor location using F(ab′)2μ from a monoclonal IgM antibody: pharmokinetics. J Nucl Med 26:283–292
Beaumier PL, Krohn KA, Carrasquillo JA, Eary J, Hellstrom I, Hellstrom KE, Nelp WB, Larson SM (1985) Melanoma localization in nude mice with monoclonal Fab against p97. J Nucl Med 26:1172–1179
Boux HA, Raison RL, Walker KZ, Hayden GE, Basten A (1983) A tumour-associated antigen specific for human kappa myeloma cells. J Exp Med 158:1769–1774
Buchegger F, Haskell CM, Schreyer M, Scazziga BR, Randin S, Carrel S, Mach J-P (1983) Radiolabelled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice. J Exp Med 158:413–427
Buraggi GL, Callegaro L, Mariani G, Turrin A, Cascinelli N, Attili A, Bombardieri E, Terno G, Plassio G, Dovis M, Mazzuca N, Natali PG, Scassellati GA, Rosa U, Ferrone S (1985) Imaging with 131I-labelled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab′)2 fragments. Cancer Res 45:3378–3387
Burton DR (1985) Immunoglobulin G: functional sites. Mol Immunol 22:161–206
Chatal J-F, Saccavini J-C, Fumoleau P, Douillard J-Y, Cunet C, Kremer M, Mevel BL, Kroprowski H (1984) Immunoscintigraphy of colon carcinoma. J Nucl Med 25:307–314
DeLand FH, Goldenberg DM (1985) Diagnosis and treatment of neoplasms with radionuclide-labelled antibodies. Semin Nucl Med 15:2–11
Colcher D, Zalutsky M, Kaplan W, Kufe D, Austin F, Schlom J (1983) Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody. Cancer Res 43:736–742
Edwards PAW, Smith CM, Neville AM, O'Hare MJ (1982) A human-human hybridoma system based on a fast-growing mutant of the ARH-77 plasma cell leukemia-derived line. Eur J Immunol 12:641–648
Goodnow CC, Raison RL (1985) Structural analysis of the myeloma-associated membrane antigen KMA. J Immunol 135:1276–1280
Kohler G, Howe SC, Milstein C (1976) Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines. Eur J Immunol 6:292–295
Lamoyi E, Nisonoff A (1983) Preparation of F(ab′)2 fragments from mouse IgG of various subclasses. J Immunol Methods 56:235–243
Larson SM (1985) Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy. J Nucl Med 26:538–545
Mach J-P, Carrel S, Merenda C, Sordat B, Cerottini J-C (1974) In vivo localisation of radiolabelled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice. Nature (Lond) 248:704–706
Mach J-P, Chatal J-F, Lumbroso J-D, Buchegger F, Forni M, Ritschard J, Berche C, Douillard J-Y, Carrel S, Herlyn M, Steplewski Z, Koprowski H (1983) Tumor localization in patients by radiolabelled monoclonal antibodies against colon carcinoma. Cancer Res 43:5593–5600
Miller WT, Smith JFG (1983) Protein iodination using iodogen. Int J Appl Radiat Isot 34:639–641
Moshakis V, McIlhinney RAJ, Raghavan D, Neville AM (1981) Localization of human tumour xenografts after i.v. administration of radiolabelled monoclonal antibodies. Br J Cancer 44:91–99
Pimm MV, Embleton MJ, Perkins AC, Price MR, Robins RA, Robinson GR, Baldwin RW (1982) In-vivo localisation of antiosteogenic sarcoma 791T monoclonal antibody in osteogenic sarcoma xenografts. Int J Cancer 30:75–85
Pimm PV, Perkins AC, Armitage NC, Baldwin RW (1985) The characteristics of blood-borne radiolabels and the effect of antimouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients. J Nucl Med 26:1011–1023
Raison RL, Boux HA (1985) Conformation dependence of a monoclonal antibody defined epitope on human kappa chains. Molec Immunol 22:1393–1398
Wahl RL, Parker CW, Philpott GW (1983) Improved radioimaging and tumor localization with monoclonal F(ab′)2. J Nucl Med 24:316–325
Waldman TA, Strober W (1969) Metabolism of immunoglobulins. Prog Allergy 13:1–110
Walker KZ, Boux HA, Hayden GE, Goodnow CC, Raison RL (1985) A monoclonal antibody with selectivity for human kappa myeloma and lymphoma cells which has potential as a therapeutic agent. In: Klaus GGB (ed) Microenvironments in the Lymphoid System. Plenum Press, New York, p 833
Yasmeen D, Ellerson JR, Dorrington KJ, Painter RH (1976) The structure and function of immunoglobulin domains. IV. The distribution of some effector functions among the Cγ2 and Cγ3 homology regions of human immunoglobulin G. J Immunol 116:518–522
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Walker, K.Z., Seymour-Munn, K., Keech, F.K. et al. A rat model system for radioimmunodetection of kappa myeloma antigen on malignant B cells. Eur J Nucl Med 12, 461–467 (1986). https://doi.org/10.1007/BF00254751
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF00254751